Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) declared a dividend on Monday, November 11th,NASDAQ Dividends reports. Investors of record on Monday, December 9th will be paid a dividend of 0.2435 per share on Friday, December 20th. The ex-dividend date of this dividend is Monday, December 9th. This is a positive change from Coloplast A/S’s previous dividend of $0.05.
Coloplast A/S Stock Down 2.6 %
OTCMKTS CLPBY traded down $0.35 on Tuesday, reaching $12.92. The company had a trading volume of 64,950 shares, compared to its average volume of 129,693. Coloplast A/S has a 52 week low of $9.90 and a 52 week high of $14.34. The company has a current ratio of 0.85, a quick ratio of 0.56 and a debt-to-equity ratio of 1.00. The stock’s 50 day moving average is $13.19 and its 200-day moving average is $12.85.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.08 earnings per share (EPS) for the quarter. The company had revenue of $1.02 billion for the quarter. Coloplast A/S had a return on equity of 31.17% and a net margin of 18.69%. As a group, analysts predict that Coloplast A/S will post 0.38 earnings per share for the current fiscal year.
Coloplast A/S Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Recommended Stories
- Five stocks we like better than Coloplast A/S
- Industrial Products Stocks Investing
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Upcoming IPO Stock Lockup Period, Explained
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.